Tommaso Pollini

Surgeon from the Verona Pancreas Institute | postdoctoral research fellow at UCSF 🇮🇹🇺🇸

[Tommaso Pollini @TomPolli1]

What an incredible experience teaching young kids about heart anatomy! Huge thanks to @Maker_MD for bringing the @UCSFSurgery spirit to our community!

[Ajay Maker @Maker_MD]

Had a fantastic time at Baywood Elementary School Science Night! 🫀✨ Students explored circulation & did hands-on heart dissections. Great way to spark curiosity in science & medicine. Huge thanks to my @UCSFSurgery colleagues who volunteered their time to inspire the next gen!

[Tommaso Pollini @TomPolli1]

Super proud of this amazing woman and surgeon, who also happens to be my wife! Looking forward for the next chapter of our life!

[Omar M Ghanem @OMGhanemMD]

Proud to announce, Dr. Sarah Mohamedaly will be joining Division of Metabolic & Abdominal Wall Reconstructive Surgery in 2025

Dr. Mohamedaly has completed her residency @UCSFSurgery & currently training in complex AWR Fellowship @ColumbiaSurgery

Welcome to @MayoClinic Sarah🏥

[Tommaso Pollini @TomPolli1]

"Trivial" IPMN out on @AGA_Gastro!

⚠️No added risk of PC in subset of IPMN compared to general population!!

➡️If you want to repeat the same analysis on your dataset, you can find the commented R code at https://t.co/gch3AYufnM

#SoMe4Surgery

[Giovanni Marchegiani @Gio_Marchegiani]

"Trivial" IPMNs as potential target of surveillance discontinuation are out now on @AGA_Gastro 🔥

🧐 After 5 years of surveillance their risk comparable to that of the general population depending on

📏 Cyst size
👴 Patient Age

But how did we get here?
https://t.co/zUaNcwhssR

[Tommaso Pollini @TomPolli1]

Credit for the picture to Thomas Bollen and their review
(https://t.co/pyMOF1CQT5)

[Tommaso Pollini @TomPolli1]

When you evaluate a pancreatic cyst like this, what is the risk of it being malignant that you share with the patient?

In our meta-analysis on 3292 resected MCN the risk was 16%!

Read the full text in the link below!

[Tommaso Pollini @TomPolli1]

The full text will be available until May 19!
https://t.co/0I8yvwHFOB

[Tommaso Pollini @TomPolli1]

Best summer school ever to learn all about #SurgicalDataScience, working with 🌎 experts both clinicians and computer scientist!
Apply!!

[CAMMA @CammaLab]

Interested in learning more about #SurgicalDataScience & endoscopic video analysis with #AI?

Join the second Surgical Data Science Summer School @IHUStrasbourg, July 17-21, 2022! #Edu4SDS

More info 👉https://t.co/W7zYL8tqej

[Tommaso Pollini @TomPolli1]

Check out our latest review on IPMN on @AnnSurgOncol!

From epidemiology 🗺️ ➡️ screening impractical!
to biomarkers 🧪 ➡️ big steps in recent years! 🔝

Thanks to @paul_wongg and @Maker_MD for the great work! @UCSFSurgery @SocSurgOnc

[Paul Wong, MD @PaulWongMD]

Honored to have been able to contribute to this important review in the Landmark Series regarding IPMN guidelines, surveillance, biomarkers, and more.

Thank you to @Maker_MD, @TomPolli1, and @AnnSurgOncol for this opportunity. @UCSFSurgery @SocSurgOnc

https://t.co/6UPFZTqEpk

[Tommaso Pollini @TomPolli1]

@DeMadaria @LancetGastroHep @Maker_MD @Gio_Marchegiani Thanks!!

[Tommaso Pollini @TomPolli1]

Out today our review on the @LancetGastroHep on the role of the immune system and microbiome during progression of IPMN to pancreatic cancer! Great international collaboration!! @Maker_MD @Gio_Marchegiani

https://t.co/9TEgPAgiF0

[Tommaso Pollini @TomPolli1]

@lelecapurso @LancetGastroHep @Maker_MD @Gio_Marchegiani @EurPancClub It was a great pleasure working with you!

[Tommaso Pollini @TomPolli1]

@SabrinaPiedimo1 @LancetGastroHep @Maker_MD @Gio_Marchegiani Thanks Sabrina!!! Hope to see you again! 🍅

[Tommaso Pollini @TomPolli1]

It’s very exciting to see new drugs and approaches make a difference for patients!

💊 ➡️ attacking desmoplastic stroma with CEND-1

🔝promising outcome 🤞🏼

!! No dose limiting toxicities !!

@LancetGastroHep

[The Lancet Gastroenterology & Hepatology @LancetGastroHep]

New research – Dean et al – CEND-1 plus nab-paclitaxel and gemcitabine for metastatic #PDAC: a first-in-human, open-label, multicentre, phase 1 study
https://t.co/jWT6AOZCWR

#GITwitter #PancreaticCancer

[Tommaso Pollini @TomPolli1]

Incredible week with incredible people at the Surgical Data Science summer schoo at @IHUStrasbourg l! #surgicaldatascience

[Federica Borrelli @FBorrelliMD]

Italian team! We had an incredible time here in Strasbourg! Looking forward to meeting you again guys! @IHUStrasbourg #edu4sds #surgicaldatascience

[SAGES is in Vegas in 2027! @SAGES_Updates]

The Supreme Court just ruled 6-3 that you don't really need to establish the Critical View of Safety.

[Tommaso Pollini @TomPolli1]

It was great to finally meet in person with @ThuyTranMD thanks to @IHPBA ! Looking forward to working together again in the future!! #IHPBA22 @Maker_MD

[Thuy Tran, MD @ThuyTranMD]

@Maker_MD mentees meeting at @ihpba #IHPBA22. @Maker_MD always finds research opportunities for his mentees. I will always be grateful to @Maker_MD for supporting and paving my path to be an academic surgeon - soon to start my first academic faculty position! @TomPolli1

[Tommaso Pollini @TomPolli1]

@nmachair @Maker_MD @IHPBA @SalviaRobi @Gio_Marchegiani Thanks nik!

[Tommaso Pollini @TomPolli1]

What a year! Life changing experience for an aspiring surgeon/scientist! So proud of the work we did! @Maker_MD @IHPBA @SalviaRobi @Gio_Marchegiani

[Ajay Maker @Maker_MD]

Congratulations @TomPolli1 on presenting biomarkers of IPMN at @IHPBA @AHPBA and receiving the Kenneth Warren Fellowship! No greater joy than seeing our mentees soar. @UCSFSurgery

[Tommaso Pollini @TomPolli1]

@Gio_Marchegiani @Maker_MD @IHPBA @SalviaRobi And many more miles to go!

[Adnan Alseidi @HPB_Surgeon]

@CalthorpeLucia, @UCSFMedicine congrats for a well done presentation “Contemporary Trends in Malignant Peritoneal Mesothelioma: Incidence and Survival in the United States” @SocSurgOnc, very proud @UCSFSurgery